New heart drug candidate passes first safety check in healthy volunteers
NCT ID NCT07033455
First seen Nov 18, 2025 · Last updated May 16, 2026 · Updated 23 times
Summary
This study looked at how safe a new drug called HRS-1893 is and how the body handles it. Twenty healthy adults took a single dose by mouth. The goal was to gather basic information before testing the drug in people with hypertrophic cardiomyopathy, a heart muscle disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTROPHIC CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Linear Clinical Research
Nedlands, Western Australia, 6009, Australia
Conditions
Explore the condition pages connected to this study.